Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raffles Medical GroupRAFLF 57 ROC (Joel Greenblatt) % is 14.07% as of Dec. 2025, which is 13% below its 10-year median of 16.26. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 51.57% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Raffles Medical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 14.07%.
The historical rank and industry rank for Raffles Medical Group's ROC (Joel Greenblatt) % or its related term are showing as below:
RAFLF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 12.23 Med: 16.26 Max: 31.1
Current: 13.25
During the past 13 years, Raffles Medical Group's highest ROC (Joel Greenblatt) % was 31.10%. The lowest was 12.23%. And the median was 16.26%.
RAFLF's ROC (Joel Greenblatt) % is ranked better than 51.57% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs RAFLF: 13.25
Raffles Medical Group's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -2.80% per year.
Raffles Medical Group (OTCPK:RAFLF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Raffles Medical Group ROC (Joel Greenblatt) % Related Terms
Raffles Medical Group ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Raffles Medical Group's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group ROC (Joel Greenblatt) % Chart
RAFLF vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Raffles Medical Group's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's ROC (Joel Greenblatt) % falls into.
Raffles Medical Group ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 14.07% mean?
Raffles Medical Group (RAFLF) has a ROC (Joel Greenblatt) % of 14.07% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Raffles Medical Group and its competitors. This is 13% below median its historical median of 16.26. Over the past decade, Raffles Medical Group's ROC (Joel Greenblatt) % has ranged from 12.23 to 31.10. According to the industry distribution chart, Raffles Medical Group ranks #324 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 48.4%.
Is Raffles Medical Group's ROC (Joel Greenblatt) % too high?
Raffles Medical Group's current ROC (Joel Greenblatt) % of 14.07% is 13% below median its 10-year median of 16.26. Over the past 10 years, this metric has ranged from a low of 12.23 to a high of 31.10. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Raffles Medical Group's value of 14.07% is 12.9% above this industry median. Based on the distribution chart, Raffles Medical Group ranks #324 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #324 out of 669 companies for ROC (Joel Greenblatt) %. This puts Raffles Medical Group in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.46. Raffles Medical Group's value of 14.07% is 12.9% above this benchmark. Historically, Raffles Medical Group's own ROC (Joel Greenblatt) % has ranged from 12.23 to 31.10 over the past decade. While the company's 10-year median is 16.26 vs. the industry median of 12.46, Raffles Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current ROC (Joel Greenblatt) % of 14.07% is 12.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current ROC (Joel Greenblatt) % is 14.07%, which is 13% below median its own 10-year median of 16.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Fairly Valued. The stock's GF Value™ is $0.75, compared to a current price of $0.75 — trading 0.4% above its estimated fair value. The current ROC (Joel Greenblatt) % is 14.07%, which is 13% below median its 10-year median of 16.26 and 12.9% above the Healthcare Providers & Services industry median of 12.46. Raffles Medical Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current ROC (Joel Greenblatt) % is 14.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be overvalued.
The current stock price of $0.75 is trading 0.4% above its estimated GF Value™ of $0.75.
GuruFocus considers Raffles Medical Group to be Fairly Valued.
Key valuation signals for RAFLF:
ROC (Joel Greenblatt) %: 14.07% (13% below median its 10-year median of 16.26)
GF Value™: $0.75 vs. price of $0.75 (0.4% above fair value)
Industry Position: 12.9% above the Healthcare Providers & Services median (#324 of 669)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score
Get the complete analysis for RAFLF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
